scholarly journals High performance web based Automated Dental Identification System

2009 ◽  
Author(s):  
Ali Bahu
2003 ◽  
pp. 287-308
Author(s):  
Rajiv Khosla ◽  
Ernesto Damiani ◽  
William Grosky

2021 ◽  
Author(s):  
Robert Haehnel ◽  
Scott Christensen ◽  
J. Whitlow ◽  
Andrew Bauer ◽  
Ari Meyer ◽  
...  

Computational Prototyping Environment (CPE) is a web-based portal designed to simplify running Department of Defense (DoD) modeling and simulation tools on the DoD Supercomputing Resource Center’s (DSRC) High Performance Computing (HPC) systems. The first of these tools to be deployed in the CPE is an application (app) to conduct parametric studies and view results using the CREATE-AV Helios CFD software. Initial capability includes hover (collective sweep) and forward flight (speed sweep) performance calculations. The CPE Helios app allows for job submission to a DSRC’s HPC system and for the viewing of results created by Helios, i.e., time series and volumetric data. Example data input and results viewing are presented. Planned future functionality is also outlined.


Author(s):  
Lichia Yiu ◽  
Raymond Saner

Since the 1990s, more and more corporate learning has been moved online to allow for flexibility, just-in-time learning, and cost saving in delivering training. This trend has been evolved along with the introduction of Web-based applications for HRM purposes, known as electronic Human Resource Management (e-HRM). By 2005, 39.67% of the corporate learning, among the ASTD (American Society for Training and Development) benchmarking forum companies, was delivered online in comparison to 10.5% in 2001. E-learning has now reached “a high level of (technical) sophistication, both in terms of instructional development and the effective management of resources” in companies with high performance learning function (ASTD, 2006, p.4). The cost per unit, reported by ASTD in its 2006 State of Industry Report, has been declining since 2000 despite the higher training hours received per employee thanks to the use of technology based training delivery and its scalability. However, the overall quality of e-learning either public available in the market or implemented at the workplace remains unstable.


2008 ◽  
Vol 123 (5) ◽  
pp. 3373-3373
Author(s):  
Valery Polyakov ◽  
Henri‐Pierre Valero ◽  
Dzevat Omeragic ◽  
Raymond L. Kocian ◽  
Tarek M. Habashy ◽  
...  

2017 ◽  
Vol 55 (10) ◽  
pp. 2924-2933 ◽  
Author(s):  
Laurence Lachaud ◽  
Anna Fernández-Arévalo ◽  
Anne-Cécile Normand ◽  
Patrick Lami ◽  
Cécile Nabet ◽  
...  

ABSTRACT Human leishmaniases are widespread diseases with different clinical forms caused by about 20 species within the Leishmania genus. Leishmania species identification is relevant for therapeutic management and prognosis, especially for cutaneous and mucocutaneous forms. Several methods are available to identify Leishmania species from culture, but they have not been standardized for the majority of the currently described species, with the exception of multilocus enzyme electrophoresis. Moreover, these techniques are expensive, time-consuming, and not available in all laboratories. Within the last decade, mass spectrometry (MS) has been adapted for the identification of microorganisms, including Leishmania . However, no commercial reference mass-spectral database is available. In this study, a reference mass-spectral library (MSL) for Leishmania isolates, accessible through a free Web-based application (mass-spectral identification [MSI]), was constructed and tested. It includes mass-spectral data for 33 different Leishmania species, including species that infect humans, animals, and phlebotomine vectors. Four laboratories on two continents evaluated the performance of MSI using 268 samples, 231 of which were Leishmania strains. All Leishmania strains, but one, were correctly identified at least to the complex level. A risk of species misidentification within the Leishmania donovani , L. guyanensis , and L. braziliensis complexes was observed, as previously reported for other techniques. The tested application was reliable, with identification results being comparable to those obtained with reference methods but with a more favorable cost-efficiency ratio. This free online identification system relies on a scalable database and can be implemented directly in users' computers.


2003 ◽  
Vol 48 (6) ◽  
pp. 2002032 ◽  
Author(s):  
Iain A. Pretty ◽  
Robert J. Pretty ◽  
Bruce R. Rothwell ◽  
David Sweet

2017 ◽  
Vol 177 (2) ◽  
pp. 239-242 ◽  
Author(s):  
Uta Neumann ◽  
Daniela Burau ◽  
Sarah Spielmann ◽  
Martin J Whitaker ◽  
Richard J Ross ◽  
...  

Objectives Due to the lack of paediatric-licensed formulations, children are often treated with individualized pharmacy-compounded adult medication. An international web-based survey about the types of medication in children with adrenal insufficiency (AI) revealed that the majority of paediatric physicians are using pharmacy-compounded medication to treat children with AI. Observations of loss of therapy control in children with congenital adrenal hyperplasia with compounded hydrocortisone capsules and regained control after prescribing a new hydrocortisone batch led to this ‘real world’ evaluation of pharmacy-compounded paediatric hydrocortisone capsules. Methods Capsule samples were collected randomly from volunteering parents of treated children suffering from congenital adrenal hyperplasia from all over Germany. Analysis of net mass and hydrocortisone content by high-performance liquid chromatography with ultraviolet (HPLC-UV) detection method was performed based on the European Pharmacopeia. Results In a total of 61 batches that were sent, 5 batches could not be analysed because of missing dose information, insufficient number of capsules or were not possible to be evaluated. Fifty-six batches containing 1125 capsules were evaluated. 21.4% of the batches revealed insufficiency in uniformity of net mass or drug content and additional 3.6% failed because they did not contain the labelled drug. Conclusions Compounded medication is a possible cause of variation of steroid doses in children with adrenal insufficiency or congenital adrenal hyperplasia, putting these vulnerable patients at risk of poor disease control and adrenal crisis. These data may apply to other individualized compounded oral medication as well, emphasizing the need for development of licensed paediatric formulations approved by regulatory authorities.


2001 ◽  
Vol 118 (10) ◽  
pp. 525-526
Author(s):  
J. Gila ◽  
A. Renner ◽  
W. Konrad ◽  
P. Veith

Sign in / Sign up

Export Citation Format

Share Document